作者: Shigeru Miyagawa , Yoshiki Sawa
DOI: 10.1007/978-981-10-2744-4_7
关键词: Ventricular assist device 、 Cell therapy 、 Internal medicine 、 Medicine 、 Angiogenesis 、 Ischemic cardiomyopathy 、 Cardiology 、 Tissue engineering 、 Heart failure 、 Cell sheet 、 Heart transplantation
摘要: Although recent progress in medications, left ventricular assist device (LVAD), or heart transplantation did a favor for failure patients, additional treatments including cell therapy and tissue engineering are required because of some drawbacks such as infections donor shortage clinical situation.